Absence of components of coagulation and fibrinolysis pathways in situ in mesothelioma.
Wojtukiewicz
M Z
MZ
Department of Medicine, Dartmouth Medical School, White River Junction, Vermont.
Zacharski
L R
LR
Memoli
V A
VA
Kisiel
W
W
Kudryk
B J
BJ
Rousseau
S M
SM
Stump
D C
DC
D001194:Asbestos / Q000009:adverse effects; D001779:Blood Coagulation Factors / Q000032:analysis*; D005342:Fibrinolysis; D006801:Humans; D007150:Immunohistochemistry; D008654:Mesothelioma / Q000097:blood*; D008954:Models, Biological; D010997:Pleural Neoplasms / Q000097:blood*
D001779:Blood Coagulation Factors; D001194:Asbestos